2 completed, 1 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Chemokines: new trials by email Literature Review of Chemokines trials Research Report on Chemokines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma. Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells - B Cell Lymphoma | Phase 2 | Unknown | Wenbin Qian | 80 | 2019-03-28 | 2019-04-26 |
| Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer Phase I - GM.CD40L.CCL21 Vaccinations, Phase II - GM.CD40L cells Vaccinations, Phase II - GM.CD40L.CCL21 Vaccinations - Lung Cancer, Adenocarcinoma | Phase 1 / Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 73 | 2012-03-26 | 2019-08-06 |
| Inducing Systemic Immunity and Regressions in Metastatic Melanoma Autologous cytokines - Metastatic Malignant Melanoma | Phase 1 | Completed | NYU Langone Health | 88 | 1978-07-01 | 2015-01-30 |
Adenocarcinoma (1) · Lung Neoplasms (1) · Lymphoma, B-Cell (1) · Melanoma (1)
H. Lee Moffitt Cancer Center and Research Institute (1) · NYU Langone Health (1) · Wenbin Qian (1)
China (1) · United States (1)
Fred T. Valentine, M.D. (1) · Jhanelle Gray, M.D. (1) · Wenbin Qian, MD，PhD (1)